Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Status:
Terminated
Trial end date:
2017-06-22
Target enrollment:
Participant gender:
Summary
This clinical research study is made up of 2 phases. The goal of Phase 1 of the study is to
test the safety of the combination of omacetaxine and decitabine and to find the best dose to
give to future patients. The goal of Phase 2 of the study is to learn if this dose can help
to control AML and/or MDS. The safety will then continue to be studied.